ECMO in COVID-19—prolonged therapy needed? A retrospective analysis of outcome and prognostic factors

BACKGROUND: The role of venovenous extracorporeal membrane oxygenation (VV ECMO) in patients with COVID-19-induced acute respiratory distress syndrome (ARDS) still remains unclear. Our aim was to investigate the clinical course and outcome of those patients and to identify factors associated with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreier, Esther, Malfertheiner, Maximilian Valentin, Dienemann, Thomas, Fisser, Christoph, Foltan, Maik, Geismann, Florian, Graf, Bernhard, Lunz, Dirk, Maier, Lars Siegfried, Müller, Thomas, Offner, Robert, Peterhoff, David, Philipp, Alois, Salzberger, Bernd, Schmidt, Barbara, Sinner, Barbara, Lubnow, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369905/
https://www.ncbi.nlm.nih.gov/pubmed/33612020
http://dx.doi.org/10.1177/0267659121995997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369905/
https://www.ncbi.nlm.nih.gov/pubmed/33612020
http://dx.doi.org/10.1177/0267659121995997

Ejemplares similares